OC

OC&C Strategy Consultants Becomes A Certified B Corporation

Retrieved on: 
Wednesday, December 6, 2023
ESG, Consultant, Carbon, Movement, B Corporation (certification), Social responsibility, Shoulder, OC, Certification, B Lab, Management

NEW YORK, Dec. 6, 2023 /PRNewswire/ -- OC&C Strategy Consultants (OC&C), the global strategy consulting firm, has become a certified B CorporationTM, joining a global community of businesses committed to balancing profit with purpose.

Key Points: 
  • NEW YORK, Dec. 6, 2023 /PRNewswire/ -- OC&C Strategy Consultants (OC&C), the global strategy consulting firm, has become a certified B CorporationTM, joining a global community of businesses committed to balancing profit with purpose.
  • As a Certified B Corporation, OC&C Strategy Consultants has undergone rigorous evaluation by B Lab, meeting high standards for social and environmental impact.
  • As a Certified B Corp, OC&C Strategy Consultants aims to demonstrate that profitability and social responsibility are not mutually exclusive but integral components of a forward-thinking and impactful business model.
  • Chris Turner, Executive Director of B Lab UK, shared: "We are delighted to welcome OC&C Strategy Consultants to the B Corp community.

OC&C Strategy Consultants Becomes A Certified B Corporation

Retrieved on: 
Tuesday, December 5, 2023
ESG, Consultant, Carbon, Movement, B Corporation (certification), Social responsibility, Shoulder, OC, Certification, B Lab, Management

WARSAW, Poland, Dec. 6, 2023 /PRNewswire/ -- OC&C Strategy Consultants (OC&C), the global strategy consulting firm, has become a certified B CorporationTM, joining a global community of businesses committed to balancing profit with purpose.

Key Points: 
  • WARSAW, Poland, Dec. 6, 2023 /PRNewswire/ -- OC&C Strategy Consultants (OC&C), the global strategy consulting firm, has become a certified B CorporationTM, joining a global community of businesses committed to balancing profit with purpose.
  • As a Certified B Corporation, OC&C Strategy Consultants has undergone rigorous evaluation by B Lab, meeting high standards for social and environmental impact.
  • As a Certified B Corp, OC&C Strategy Consultants aims to demonstrate that profitability and social responsibility are not mutually exclusive but integral components of a forward-thinking and impactful business model.
  • Chris Turner, Executive Director of B Lab UK, shared: "We are delighted to welcome OC&C Strategy Consultants to the B Corp community.

SFA Therapeutics Announces Updated Psoriasis Data for SFA-002, Bridge Financing, and Foundational Patent

Retrieved on: 
Thursday, November 9, 2023
FRSC, Psoriasis, MD–PhD, Patent, Composition of matter, SFA, TB, Cytokine, FRCPC, University, Research, Psoriasis Area and Severity Index, Conditional sentence, IGA, Disease, Cancer, Autoimmune disease, OC, Infection, Safety, Therapy, Patient, PASI, Immunosuppression, Toxic leukoencephalopathy, Pharmaceutical industry

Additional participants in this raise were the Ben Franklin Technology Partners of Pennsylvania, Savantus Ventures and Asymmetry Ventures.

Key Points: 
  • Additional participants in this raise were the Ben Franklin Technology Partners of Pennsylvania, Savantus Ventures and Asymmetry Ventures.
  • SFA-002 is an oral pill that simultaneously acts on multiple therapeutic pathways, unlike other drugs on the market which target a single channel.
  • SFA Therapeutics is also pleased to announce that North South Ventures Managing Partner, Dr. David Naylor, MD/PhD, OC, FRCPC, FRSC, has joined SFA Therapeutics’ Board of Directors.
  • Psoriasis is an incurable chronic disease that affects 125 million people worldwide, with the global psoriasis treatment market size projected to grow at a CAGR of 9.2%.

Owens Corning’s Philanthropic Roof Deployment Project Crosses Milestone of Providing 500 Free Roofs to U.S. Veterans

Retrieved on: 
Tuesday, November 7, 2023
Residential Building & Real Estate, Other Retail, Construction & Property, Philanthropy, Interior Design, Specialty, Other Philanthropy, Retail, Foundation, Home Goods, Other Construction & Property, Owens Corning, Element, Army National Guard, NYSE, Veteran, Multimedia, Corning, Social responsibility, OC, Platinum, Shingles, Glass fiber

View the full release here: https://www.businesswire.com/news/home/20231106659168/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231106659168/en/
    The program, which began in 2016, recently crossed the milestone of 500 free roofs provided to U.S. veterans in need just in time to commemorate Veterans Day 2023.
  • Through the program, Owens Corning provides the shingles and roofing components at no cost and Platinum Preferred Contractors donate the labor to install the roofs.
  • “Veterans are our nation’s heroes, and we owe them our gratitude,” said Gunner Smith, Roofing Business President at Owens Corning.
  • The Roof Deployment Project is a testament to our dedication to social responsibility and engagement with our communities.”

Wistar Scientists Engineer New NK cell Engaging Immunotherapy Approaches to Target and potentially Treat recalcitrant Ovarian Cancer

Retrieved on: 
Wednesday, November 1, 2023
Ovarian cancer, Neoplasm, Survival, VIC, Wistar Institute, Biomedical Research, Hook effect, Siglec, Sial, Infection, Cell biology, BRCA1, FSHR, PD-1, Nature, BRCA, Research, Follicle-stimulating hormone, University of Pennsylvania, Observation, CPI, BRCA2, CDC, Vaccine, Immune system, NK, Risk, Antibody, Cancer, Cancer research, Wistar, Natural killer T cell, Perelman School of Medicine at the University of Pennsylvania, University, OC, NIH, Culture, Woman, Patient, Toxicity, PARP, Pharmaceutical industry, Fine chemical, Monoclonal antibody, Science Advances

Ovarian cancer demonstrates a low response rate to standard-of-care treatments like chemotherapies, PARP inhibitors and the widely used checkpoint inhibitor, PD-1.

Key Points: 
  • Ovarian cancer demonstrates a low response rate to standard-of-care treatments like chemotherapies, PARP inhibitors and the widely used checkpoint inhibitor, PD-1.
  • In the small proportion of ovarian cancer patients that do respond to these treatments, resistance becomes problematic over time — resulting in tumor escape and cancer progression.
  • NK cells have been recently described to express Siglec-7, so the team tested two new strategies to engage and activate NK cells against ovarian cancer through Siglec-7.
  • Wistar scientists are focused on solving some of the world’s most challenging and important problems in the field of cancer, infectious disease, and immunology.

Recognizing and Celebrating Outstanding Contributions to the Canadian Cancer Research Community

Retrieved on: 
Monday, November 6, 2023
Women of Outstanding Achievement Photographic Exhibition, FRSC, ISCB Senior Scientist Award, Order of Ontario, FCAN, Medical research, Myeloma Canada, Molecular biology, Multiple myeloma, FRS, Genetics, Jewish General Hospital, Psycho-oncology, RN, Conference, Organization, Federation, Doctor of Philosophy, FRCPC, Doctor of Science, University of Hong Kong, Research, Toronto Metropolitan University, Patient, Senior, McGill University, Princess Margaret Cancer Centre, Professor, University of Toronto, Immune system, Canadian Partnership Against Cancer, University, OC, FCAHS, Palliative care, Distinguished Service to Music Medal, CCRA, Toronto, Breast cancer, University Health Network, University of Manitoba, Ovarian Cancer Research Alliance, Pharmaceutical industry, Nursing, Management, MD, Pharmacology, Cancer

TORONTO, Nov. 6, 2023 /CNW/ - Today, the Canadian Cancer Research Alliance (CCRA) announces the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.

Key Points: 
  • TORONTO, Nov. 6, 2023 /CNW/ - Today, the Canadian Cancer Research Alliance (CCRA) announces the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.
  • Awardees will be honoured at the Canadian Cancer Research Conference, which is taking place in Halifax from November 12 to 14.
  • Initiated in 2011, the CCRA Awards acknowledge and celebrate the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community, as well as those who have shown exceptional leadership in patient involvement in cancer research.
  • The Canadian Cancer Research Alliance (CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted in Canada – research that will lead to better ways to prevent, diagnose, and treat cancer, and improve patient and survivor outcomes.

NATIONAL SUMMIT TO TACKLE URGENT NEED FOR COMPREHENSIVE CAREGIVING STRATEGY

Retrieved on: 
Monday, November 6, 2023
Person, David Azrieli, United Kingdom, Policy, Shaw Centre, System, Public policy, US, Job satisfaction, Community Living Assistance Services and Supports Act, R&B, Administration, Summit, Hon, Azrieli Center, Caregiver, Shaw Centre for the Salish Sea, Lords, OC, Disability, House, Residential care, Nursing

"CCCE supports caregivers and care providers in Canada, but public policy reform is needed to fully address the care crisis in Canada."

Key Points: 
  • "CCCE supports caregivers and care providers in Canada, but public policy reform is needed to fully address the care crisis in Canada."
  • The Summit brings together experts with lived experiences as caregivers, leaders, policymakers and researchers from the age, disability, and illness communities to help lay the groundwork for a national caregiving strategy.
  • "Our summit is the first national convening bringing together stakeholders from across the lifespan to lay the groundwork for a national caregiving strategy to address the many challenges faced by caregivers and care providers and ensure they have the supports they need and deserve."
  • To better understand the needs of caregivers and care providers across Canada, CCCE collaborated with Leger Communications to conduct the National Caregiving Survey in the summer of 2023.

Riverpoint Medical Receives FDA Approvals for OC Coating Technology of Textile and Fiber

Retrieved on: 
Thursday, October 26, 2023
OC, FDA, Medicine, Federal Food, Drug, and Cosmetic Act, Patient, AAOS, Pharmaceutical industry, Medical device

PORTLAND, Ore., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Riverpoint Medical is thrilled to announce its success in securing its first FDA 510k's for OC Coating Technology.

Key Points: 
  • Riverpoint Medical is thrilled to announce its success in securing its first FDA 510k's for OC Coating Technology.
  • PORTLAND, Ore., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Riverpoint Medical is thrilled to announce its success in securing its first FDA 510k's for OC Coating Technology.
  • Riverpoint Medical's proprietary coating technology integrates osteoconductive bioceramic materials into the surface of the medical textile, offering a revolutionary biological solution for various medical devices.
  • Doug King, CEO of Riverpoint Medical, stated, "This marks another pivotal step for Riverpoint Medical in delivering novel solutions to advance the quality of medical devices for our partners and patients.

Owens Corning Earns Top 10 Ranking on 2023 List of 100 Best Corporate Citizens

Retrieved on: 
Wednesday, October 18, 2023
Professional Services, Sustainability, Recycling, Residential Building & Real Estate, Commercial Building & Real Estate, Environment, Construction & Property, Other Manufacturing, Green Technology, Building Systems, Environmental, Social and Governance (ESG), Manufacturing, NYSE, ESG, Sustainable Development Goals, Paris, Institutional Shareholder Services, Responsibility, Russell 1000 Index, Human rights, OC, Paris Agreement, ISS, Climate change, Arms industry, Management

Owens Corning (NYSE: OC) has been named to the annual 100 Best Corporate Citizens ranking by 3BL.

Key Points: 
  • Owens Corning (NYSE: OC) has been named to the annual 100 Best Corporate Citizens ranking by 3BL.
  • For the sixth consecutive year, Owens Corning placed in the top 10 of the 100 Best Corporate Citizens list.
  • Data and information used in the 2023 edition of the 100 Best Corporate Citizens ranking were collected from July 2022 to July 2023.
  • “The 100 Best Corporate Citizens of 2023 are answering the call by demonstrating societal and bottom-line value of leadership and transparency around ESG topics,” Armon added.

Owens Corning Unveils 2024 Shingle Color of the Year: Williamsburg Gray

Retrieved on: 
Wednesday, October 18, 2023
Interior Design, Retail, Other Construction & Property, Home Goods, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Midnight, Owens Corning, Weather, NYSE, Family, Friends, Multimedia, OC, Woman, Shingles, Dimension stone

Owens Corning (NYSE: OC) today unveiled “Williamsburg Gray” as the 2024 Shingle Color of the Year (SCOTY).

Key Points: 
  • Owens Corning (NYSE: OC) today unveiled “Williamsburg Gray” as the 2024 Shingle Color of the Year (SCOTY).
  • View the full release here: https://www.businesswire.com/news/home/20231018276348/en/
    Owens Corning introduced “Williamsburg Gray” as the 2024 Shingle Color of the Year (SCOTY).
  • Williamsburg Gray offers a new take on a conventional interpretation of gray; and to complement it, Owens Corning is introducing new design resources to inspire homeowners.
  • “While Williamsburg Gray is indeed a traditional shade, the undertones evoke the sense of timelessness seen in nature.” The announcement of Williamsburg Gray as the 2024 Shingle Color of the Year follows the selection of “Midnight Plum,” the industry’s first “purple-inspired” shingle, in 2023.